Pharmaceuticals stories
QuEra survey finds quantum buyers and backers are demanding stronger proof of value, even as 46% of organisations expect budgets to stay flat.
The new specialisation should help healthcare and life sciences firms use governed AI and data tools to speed trials, discovery and patient insights.
AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.
Neoqura hires The Optimisers for US expansion as it readies Asteroid Ointment, backed by a NZD $2 million crowdfunding plan.
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
The new tools give life sciences finance teams clearer trial spending forecasts and scenario planning after a USD $24 million Series A round.
Factories face the highest cyber exposure, with industrial manufacturers hit by 1,567 attacks a week and 1,607 breaches a year, Digitain says.
Practical use, not price, is now the main hurdle for quantum AI adoption, as SAS readies a tool for Viya customers later this year.
Consumers are set to encounter AI in robots, transport and personalised shopping, as Forrester says business returns will arrive sooner than expected.
A trust-backed board majority now gives Anthropic tighter oversight as it seeks to balance rapid AI growth with its public benefit mission.
The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.
Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.
The hire is meant to sharpen the consultancy's North American push as clients demand clearer returns from AI and transformation spending.
Water scarcity is emerging as a constraint on AI buildouts, with a new Oxfordshire plant set to recycle most cooling water on site.
Enterprise AI projects across Europe will move beyond pilots as the tie-up targets secure deployment inside core business processes.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
Nearly all Scottish tech firms now use AI, with full adoption doubling to 18% as sales and cashflow improve despite softer confidence.
Rising storms, labour shortages and cargo fires are increasing costs and disruption for Asian shipping firms, QBE warns.
The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.